Skip to content

CARDIFF ONCOLOGY, INC.: 10-Q filed 2018-11-07

What CARDIFF ONCOLOGY, INC. reported in its quarterly report filed 2018-11-07 (fiscal Q3 2018): 35 published measures, 98 facts as tagged in accession 0001628280-18-013880.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-07
Fiscal period
fiscal Q3 2018
Accession
0001628280-18-013880 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CARDIFF ONCOLOGY, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-3017,920,822USD
At 2017-12-3112,284,941USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-09-303,941,067USD
At 2017-12-315,778,834USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-3013,979,755USD
At 2017-12-316,506,107USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-3015,065,913USD
At 2017-12-318,225,764USD
At 2017-09-307,434,298USD
At 2016-12-3113,915,094USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-3,769,568USD92
2018-01-01 to 2018-09-30-12,302,700USD273
2017-07-01 to 2017-09-30-4,291,966USD92
2017-01-01 to 2017-09-30-22,337,314USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-305,100USD273
2017-01-01 to 2017-09-30136,251USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-30-188,026,677USD
At 2017-12-31-173,046,186USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-07-01 to 2018-09-3020,622,660shares92
2018-01-01 to 2018-09-3010,945,249shares273
2017-07-01 to 2017-09-303,038,806shares92
2017-01-01 to 2017-09-302,735,526shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-07-01 to 2018-09-3020,622,660shares92
2018-01-01 to 2018-09-3010,945,249shares273
2017-07-01 to 2017-09-303,038,806shares92
2017-01-01 to 2017-09-302,735,526shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-0.18USD/shares92
2018-01-01 to 2018-09-30-1.38USD/shares273
2017-07-01 to 2017-09-30-1.41USD/shares92
2017-01-01 to 2017-09-30-8.17USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-0.18USD/shares92
2018-01-01 to 2018-09-30-1.38USD/shares273
2017-07-01 to 2017-09-30-1.41USD/shares92
2017-01-01 to 2017-09-30-8.17USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-301,627,605USD
At 2017-12-312,426,312USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,905,652USD273
2017-01-01 to 2017-09-303,117,364USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-3,855,308USD92
2018-01-01 to 2018-09-30-12,949,927USD273
2017-07-01 to 2017-09-30-5,797,621USD92
2017-01-01 to 2017-09-30-21,811,520USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-3016,043,572USD
At 2017-12-319,468,687USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-07-01 to 2018-09-3016USD92
2018-01-01 to 2018-09-3025,177USD273
2017-07-01 to 2017-09-3037,123USD92
2017-01-01 to 2017-09-301,010,256USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-302,666,611USD
At 2017-12-313,945,770USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-09-30476,300USD
At 2017-12-31825,244USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-30128,577USD
At 2017-12-3177,095USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-303,943,669USD92
2018-01-01 to 2018-09-3013,250,237USD273
2017-07-01 to 2017-09-305,920,950USD92
2017-01-01 to 2017-09-3022,131,898USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-07-01 to 2018-09-3026,677USD92
2018-01-01 to 2018-09-30597,457USD273
2017-07-01 to 2017-09-30473,202USD92
2017-01-01 to 2017-09-301,427,831USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,665,200USD92
2018-01-01 to 2018-09-306,321,048USD273
2017-07-01 to 2017-09-304,079,514USD92
2017-01-01 to 2017-09-3012,358,290USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-3022,957,192shares
At 2017-12-314,399,299shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-30201,998,634USD
At 2017-12-31179,546,954USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-09-303,979,610USD
At 2017-12-314,497,804USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-09-302,352,005USD
At 2017-12-312,071,492USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-09-30249,645USD
At 2017-12-31389,942USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-09-301,718,060USD
At 2017-12-311,454,587USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2018-09-30849,082USD
At 2017-12-311,165,828USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-3,769,568USD92
2018-01-01 to 2018-09-30-12,302,700USD273
2017-07-01 to 2017-09-30-4,293,510USD92
2017-01-01 to 2017-09-30-22,341,735USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-3,775,628USD92
2018-01-01 to 2018-09-30-15,090,413USD273
2017-07-01 to 2017-09-30-4,298,026USD92
2017-01-01 to 2017-09-30-22,355,494USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2018-01-01 to 2018-09-30701,774USD273
2017-01-01 to 2017-09-30956,995USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,318USD92
2018-01-01 to 2018-09-30-68,521USD273
2017-07-01 to 2017-09-30-6,541USD92
2017-01-01 to 2017-09-30-4,975USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2018-01-01 to 2018-09-3011,779,525USD273
2017-01-01 to 2017-09-306,634,803USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-58,440USD273
2017-01-01 to 2017-09-3077,667USD273

Inspect the source

Entity
CARDIFF ONCOLOGY, INC. / CIK 0001213037
Captured
2026-09-20T07:45:48.177Z
SEC response SHA-256
5fefa7380123168da913afadb8db67f9296559e6467fa58ab3879c6c623fb326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001213037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))